APA (7th ed.) Citation

CR, D., N, M., CM, A., A, G., M, M., R, V. G., . . . YG, S. (2021). A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel, Switzerland), 14(8), . https://doi.org/10.3390/ph14080749

Chicago Style (17th ed.) Citation

CR, Dart, et al. "A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine." Pharmaceuticals (Basel, Switzerland) 14, no. 8 (2021). https://doi.org/10.3390/ph14080749.

MLA (9th ed.) Citation

CR, Dart, et al. "A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine." Pharmaceuticals (Basel, Switzerland), vol. 14, no. 8, 2021, https://doi.org/10.3390/ph14080749.